mklives

SUNPHARMA.. bullish?

做多
mklives 已更新   
NSE:SUNPHARMA   SUN PHARMACEUTICAL
SUNPHARMA after a long time, is crossing 200 dma
news about the whistle blower went in favour of the company
can be a contrarion bet in a weak market
above 441 close, can give 10 % returns possibly.
评论:
sun pharma breaks above 200 dma which is good.. rsi above 60.
buy on dips to 441 and targets of 485 as first target. weekly rsi has double bottomed. looks like 500 can be tested but is a strong resistance since it is 100 weekly dma

免责声明

这些信息和出版物并不意味着也不构成TradingView提供或认可的金融、投资、交易或其它类型的建议或背书。请在使用条款阅读更多信息。